International study finds increased COVID-19 mortality among adults with Down syndrome

February 22, 2021

A new study by an international team of researchers found that adults with Down syndrome are more likely to die from COVID-19 than the general population, supporting the need to prioritize vaccinating people with the genetic disorder.

Investigators found that adults with Down syndrome were roughly three times more likely to die from COVID-19 than the general population. This increased risk was especially apparent in from fifth decade of life: A 40-year-old with Down syndrome had a similar risk of dying from COVID-19 as someone 30 years older in the general population.

The study was published this week in The Lancet's EClinical Medicine.

"Our results, which are based on more than 1,000 COVID-19 unique patients with Down syndrome, show that individuals with Down syndrome often have more severe symptoms at hospitalization and experience high rates of lung complications associated with increased mortality," said Anke Huels, an assistant professor of epidemiology at Emory University's Rollins School of Public Health, and the study's first author. "These results have implications for preventive and clinical management of COVID-19 patients with Down syndrome and emphasize the need to prioritize individuals with Down syndrome for vaccination."

Down syndrome is a genetic condition typically caused by the trisomy--or having an extra copy--of chromosome 21. This extra copy changes how a baby's body and brain develop, which can cause both mental and physical challenges.

To collect data for the study, T21RS COVID-19 Initiative launched an international survey of clinicians and caregivers of individuals with Down syndrome infected with COVID-19 between April and October, 2020. Survey respondents were mainly from Europe, the United States, Latin America and India. (The survey was available in English, Spanish, French, Italian, Portuguese, German, Bengali, Hindi and Mandarin).

"We are delighted to see that, partly based on our findings, the CDC included Down syndrome in the list of 'high-risk medical conditions,' which will prioritize those with this genetic condition for vaccination," said co-author Alberto Costa, professor of pediatrics and psychiatry at the Case Western Reserve University School of Medicine. "Similar decisions have been made in the United Kingdom and Spain, and we hope that other countries will soon follow."
-end-
Costa is among the leaders of a large and diverse group of physicians and scientists from seven countries and more than a dozen institutions collaborating to study the impact of COVID-19 in people with Down syndrome, called the T21RS COVID-19 Initiative.

The T21RS COVID-19 Initiative is part of an effort established in March 2020 by the Trisomy 21 Research Society (T21RS) to gather and disseminate scientific information to support communities of individuals with Down syndrome and their families internationally during the pandemic. The T21RS was founded in 2014 and is the world's largest professional Down syndrome research society.

Costa is chair of the Clinical Research Committee of T21RS and one of the founding members of the T21RS COVID-19 Initiative. The other members of the T21RS COVID-19 Initiative leadership team are Huels and Stephanie Sherman, of Emory University, Andre Strydom, of King's College London, and Mara Dierssen, of the Barcelona Institute of Science and Technology.

Funding for the study was provided by: Down Syndrome Affiliates in Action, Down Syndrome Medical Interest Group-USA, GiGi's Playhouse, Jerome Lejeune Foundation, LuMind IDSC Foundation, Matthews Foundation, National Down Syndrome Society, National Task Group on Intellectual Disabilities and Dementia Practices. Costa received support from the Alana USA Foundation, the Infectious Diseases Society of America and the Cleveland-based Awakening Angels Foundation.

Case Western Reserve University is one of the country's leading private research institutions. Located in Cleveland, we offer a unique combination of forward-thinking educational opportunities in an inspiring cultural setting. Our leading-edge faculty engage in teaching and research in a collaborative, hands-on environment. Our nationally recognized programs include arts and sciences, dental medicine, engineering, law, management, medicine, nursing and social work. About 5,100 undergraduate and 6,700 graduate students comprise our student body. Visit case.edu to see how Case Western Reserve thinks beyond the possible.

Case Western Reserve University

Related Genetic Disorder Articles from Brightsurf:

Molecular cause underlying rare genetic disorder revealed
Scientists identify how a nonfunctioning CASK gene creates chaos in the brain.

Study of rare genetic disorder that effects the eyes
Small gauge vitrectomy for vitreous amyloidosis and subsequent management of secondary glaucoma in patients with hereditary transthyretin amyloidosis.

The rare genetic disorder identified in only 3 people worldwide
A team of South Australian researchers has cracked a rare gene variant for a disorder that causes severe neurodegeneration in infants.

Researchers discover genetic mutation behind serious skull disorder
An international collaboration has identified a new genetic mutation behind the premature fusing of the bony plates that make up the skull.

New study first to identify cause of rare genetic metabolic disorder
A new study from BC Children's Hospital, the University of British Columbia (UBC) and an international team of researchers published in the New England Journal of Medicine is the first to identify a rarely-seen type of DNA mutation as the cause of an inherited metabolic disorder.

Common genetic disorder linked to more disease than previously thought
The most common genetic disorder in people from northern Europe is associated with substantially higher levels of disease than previously thought, despite being easy to detect and treat, finds a study published in The BMJ today.

First genetic map of the Attention Deficit Hyperactivity Disorder
An international study, focused on the analysis of the genome of more than 50,000 people worldwide, has identified twelve specific fragments of DNA related to the vulnerability of the attention deficit hyperactivity disorder (ADHD).

MSU-Spectrum Health researchers identify new genetic disorder
Researchers from Michigan State University College of Human Medicine and physicians from Spectrum Health have identified for the first time in a human patient a genetic disorder only previously described in animal models.

Gene-editing technique cures genetic disorder in utero
Researchers at Carnegie Mellon University and Yale University have for the first time used a gene editing technique to successfully cure a genetic condition in a mouse model.

Team identify genetic targets for autism spectrum disorder
Early detection of autism in children is key to producing the best outcomes; however, searching for the genetic causes of autism is complicated by various symptoms found within the spectrum.

Read More: Genetic Disorder News and Genetic Disorder Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.